The neural crest (NC) is a multipotent migratory embryonic population that is formed during late gastrulation and gives rise to a wide array of derivatives, including cells from the peripheral nervous system (PNS), the craniofacial bones and cartilages, peripheral glial cells, and melanocyte cells, among others. In this work we analyzed the role of the Hedgehog signaling pathway effector gli2 in Xenopus NC. We provide evidence that the gli2 gene is expressed in the prospective, premigratory and migratory NC. The use of a specific morpholino against gli2 and the pharmacological specific inhibitor GANT61 in different experimental approaches allowed us to determine that gli2 is required for the induction and specification of NC cells as a transcriptional activator. Moreover, gli2 also acts by reducing apoptosis in the NC without affecting its cell proliferation status. We also demonstrated that gli2 is required cell-autonomously for NC migration, and for the formation of NC derivatives such as the craniofacial cartilages, melanocytes and the cranial ganglia. Altogether, our results showed that gli2 is a key transcriptional activator to accomplish the proper specification and development of Xenopus NC cells.
Introduction
The neural crest (NC) is a multipotent embryonic cell population with stem-cell-like properties that arises at the border between the neural plate (NP) and the prospective epidermis, and migrate along the entire embryo. This cell population, which separates the craniates/ vertebrates from other metazoans, has played a key role in the evolutionary development of the jaw and other cranial structures (Saint-Jeannet, 2006) . Derivatives from the NC include neurons and glia of the sensory, autonomic and enteric nervous system, medullary secretory cells, bone marrow cells from the femur and other long bones, smooth muscle cells, melanocytes, bone and cartilage cells, among other cell types (Couly et al., 1998; Keyte et al., 2014; Vega-Lopez et al., 2017) . Increasing research in recent years has focused on NC development based on the fact that the abnormal formation of this cell population can give rise to a diverse class of pathologies known as neurocristopathies (NCP), which affect a large proportion of newborns (Vega-Lopez et al., 2018; Watt and Trainor, 2014) . Therefore, studying the mechanisms underlying NC formation is a necessary step for the isolation of multipotent NC stem cells that could act as potential sources for the treatment of several of these NCP and many NC-related cancers (Liu and Cheung, 2016) .
Interactions between distinct signaling pathways such as BMP, FGF, Notch and Wnt play a key role in the development of the NC. These signals, along with other molecules, participate in establishing a gene regulatory network that is crucial to determine NC identity (Martik and Bronner, 2017; Sauka-Spengler and Bronner-Fraser, 2008) . Hedgehog (Hh) ligands include Sonic Hedgehog (Shh), Indian Hedgehog (Ihh) and Desert Hedgehog (Dhh) (Wu et al., 2017) . We have previously found in Xenopus embryos that the Indian Hedgehog (Ihh) signaling pathway is active in the NC tissue, and that it is required for the development of this cell population (Aguero et al., 2012) . We also revealed the regulatory relationships between this pathway and the eg5 gene in the NC (Fernandez et al., 2014) . The Hh signaling pathway plays important roles in development, tissue homeostasis and tumorigenesis. Signaling is initiated when the ligand binds to the receptor Patched1 (Ptch1).
When unbound, Ptch1 inhibits the activity of a second receptor called Smoothened (Smo) , which is responsible for the activation of the pathway effectors, the Gli transcription factors (Gli1, Gli2 and Gli3). These transcription factors are post-translationally regulated and act in a context-dependent combinatorial fashion (Chen and Jiang, 2013; Ruiz i Altaba et al., 2007) . When the Hh signal is absent, Gli2 and Gli3 are proteolytically processed into repressor forms (GliRep), whereas when the pathway is active, they act as full length transcriptional activators (GliAct) (Hui and Angers, 2011) .
Gli2, the main activator of the Hh signaling pathway, stimulates the transcription of several target genes (Kim et al., 2009) . In Xenopus embryogenesis, Gli proteins play a crucial role during neurogenesis, inducing different neuronal types through a cooperative and combinatorial action (Nguyen et al., 2005) . Gli2 has been shown to participate in several developmental processes, acting as a transcriptional activator. These processes include palate development (Mo et al., 1997) , lung and pituitary gland formation (Ding et al., 1998; Wang et al., 2010) and the generation of the central nervous system (Chen et al., 2018; Lepanto et al., 2016; Matise et al., 1998) . However, a repressor function of Gli2 has also proved to be important for the development of the zebrafish nervous system (Karlstrom et al., 2003) . Therefore, since Gli2 regulates many cellular processes, it has been associated with disease when its regulation goes awry (reviewed in (McCleary-Wheeler, 2014) ). The growing number of therapeutic applications based on the function of Gli2 has generated a dramatic increase in the number of studies that analyze the function of this transcription factor. Nevertheless, despite great advances in the understanding of the mechanisms underlying the function of Gli2 during central nervous system development, little is known about the role of this transcription factor in the formation of the NC.
In this work we address the participation of Gli2 in the formation of Xenopus laevis NC. We made a detailed analysis of the spatio-temporal expression pattern of this gene, thus complementing previous reports. Furthermore, using gain and loss-of function studies and RT-qPCR analysis, we show that gli2 is essential for the induction, specification and maintenance of the specification and migration of the NC. Mechanistically, our results also provide evidence that Gli2 is acting as a transcriptional activator in NC development. We also suggest that Gli2 might be required for the formation of NC derivatives such as craniofacial cartilages, melanocytes, Rohon Beard (RB) neurons and cranial ganglia primordia. By taking advantage of the Gli2-specific inhibitor GANT61, we corroborated the results obtained with the standard morpholino-based knock down approach. To summarize, by different approaches we have addressed the participation of this transcription factor in the formation of the NC.
Results

Spatio-temporal expression patterns of gli2 and Ptc1
Using simple and double in situ hybridizations (ISH), we performed a comprehensive analysis of the spatio-temporal expression pattern of the gli2 gene during the initial development of Xenopus laevis. During late gastrulation (stages 12 and 13), the expression of gli2 was observed in the dorsal region of the embryos at the anterior NP border (NPB) extending through the NP posteriorly with no expression at the dorsal midline. This gene was also expressed in the lateral posterior NPB ( Fig. 1A-B ). At mid-neurula stages (st. 15-16) , the expression increased in the NPB (Fig. 1C-D, yellow arrowheads) , which corresponds to the prospective NC. During the course of neurulation we detected gli2 transcripts in the anterior NP (black arrow). As development proceeded, at stages 16-17 ( Fig. 1E, asterisk) gli2 expression was also observed in the mesoderm. When NC cells (NCC) started to migrate from the dorsal region of the embryo (stage 18), the expression of gli2 was located in the NC migratory region without apparent expression in the midline (Fig. 1F-G) . Additionally, at tailbud stages ( Fig. 1H-I) , gli2 transcripts were detected in the head region of the embryo. Stage 24embryos showed expression in the prospective branchial arches, in particular in the mandibular and hyoid NC streams, and also in the optic vesicle. Afterwards, at stage 32, the expression became more prominent in the boundaries between the branchial arches. At this point, gli2 expression in the optic vesicle became restricted to its borders. Additionally, gli2 was detected in the otic vesicle and in the segmentative presomitic mesoderm.
To further delineate the expression of gli2 in the NC, we performed (caption on next page) double ISH with NC and NP markers. At stage 15, a double ISH of gli2 with the NC marker foxd3 showed a clear overlapping expression of both genes in the inner region of the NC (Fig. 1J ). Transversal sections of these embryos revealed that gli2 expression occurred mainly in the internal ectodermal layer corresponding to the NP and prospective NC ( Fig. 1J′ ). Then we analyzed the NP marker sox2 and found an overlap in the expression of both genes in the lateral region of the NP as summarized in Fig. 1K -K′. Additionally, gli2 expression (white arrowhead) expanded more anteriorly than that of sox2 ( Fig. 1K″ , anterior view, green arrowhead). These initial results suggest that gli2 is mainly expressed in the NC territory during late gastrulation and throughout neurulation.
It is well known that ptch1 serves as a readout of the Hh signaling pathway as its expression is increased in response to the activation of the Hh pathway (Goodrich et al., 1996) . Therefore, analyzing the expression pattern of the Ptch1 protein could provide useful information about the embryonic locations where the Hh signaling is active. To that end, we analyzed the expression of the Ptch1 receptor by performing a wholemount immunohistochemistry (IHC) assay. We found that Ptch1 is expressed in the ectoderm at the dorsal side of the embryo (Fig. 1L ) at the gastrulation stage 11. By the end of gastrulation, at stages 12.5-13, is expressed in the dorsolateral region of the embryo at stages 12.5 and 13 (yellow arrowheads). (C-D) gli2 transcripts are detected in the NPB at early neurula stage (yellow arrowheads) and in the anterior NP (black arrow). No expression can be observed in the dorsal midline (red arrowhead) (E-G). From stage 17 to 19, gli2 becomes more prominent in the lateral and anterior NPB. (H-I) At tailbud stages, gli2 is expressed in the mandibular (mb) and hyoid (hy) NC streams, in the branchial arches (b.a.), in the otic (Ot) and optic (Op) vescicle and in the presomitic mesoderm (S). (J-K) Double ISH showing gli2 expression with two gene markers. (J-J') gli2 is expressed in an overlapping territory with the NC marker foxd3. (K-K′) The domain of gli2 expression extends laterally from the NP, as evidenced by the double ISH with sox2 in whole embryos. (K″) Anterior view showing that the expression of gli2 extends mores anteriorly than that of sox2. (L) At the late gastrula stage, Ptch1 is expressed in the dorsal side of the blastopore. (M-O) At neurula stages, Ptch1 can be detected in the NPB and in the neural folds. (O′) Expression of Ptch1 in the cell membranes of ectodermal cells. (P) Diagram representing the expression domains of the Ptch1 protein (green) and the genes gli2 (blue), foxd3 (light yellow) and sox2 (pink). Ptch1 is expressed in the anterior NPB ( Fig. 1M , yellow arrowheads) and is faintly expressed in the lateral NPB. At neurulation stages the expression of Ptch1 increases in the elevating neural folds, as depicted in Fig. 1N -O. Fig. 1O′ is a magnification of Ptch1 expression in the uprising neural folds that clearly shows Ptch1 expression in the NC cell outlines. This expression profile agrees with its role as a transmembrane receptor. To summarize, the scheme in Fig. 1P shows the different domains of expression of gli2 (blue) and Ptch1 (green) along with the neural crest (foxd3, light yellow) and neural (sox2, pink) markers.
Taken together, these results provide compelling evidence that gli2 is expressed in the prospective, premigratory and migratory NC, thus supporting a potential role in NC formation. In addition, the analysis of Ptch1 expression shows strongly suggesting that the Hh signaling pathway is active in this cell population.
gli2 is required for the early induction of the NC
The process of NC induction is complex and involves several steps of signal inputs, protein-protein interactions, and the combinatorial activity of different transcription factors. More specifically, during the early steps of NC formation, several molecules including signaling peptides and transcription factors act to establish the NPB, which thereof acquires a different molecular identity from the surrounding neural and non-neural ectoderm. Together, these factors are called NPB specifiers. These specifiers include the transcription factors pax3, snail1 and msx1 (Mayanil, 2013) .
Initially, in order to analyze the requirement of gli2 during the early steps of NC induction, we used the directed microinjection of a morpholino oligonucleotide against the translation initiation site of the gli2 mRNA, called gli2MO. As a first step we decided to evaluate the efficiency of gli2MO against gli2 in vivo and in vitro. A plasmid encoding a chimeric protein consisting of the first 92 aminoacid residues of Gli2 fused to a GFP protein (gli2GFP) was constructed. Subsequently we injected different amounts of gli2MO along with the mRNA of the gli2GFP, and the expression of GFP by fluorescence microscopy and Western blotting was evaluated. The injection of a control morpholino (CoMO) along with gli2GFP mRNA did not affect GFP expression in the embryo ( Fig. 2A , 100% of embryos, n = 25). As shown in Fig. 2B -C the injection of 2.5 ng/E and 5 ng/E of gli2MO caused a reduction in GFP expression in a dose dependent manner (100%, n = 25, and 95%, n = 25, respectively). At a gli2MO concentration of 10 and 27 ng/E the fluorescence was completely abolished ( Fig. 2D -E, 100%, n = 25). To further analyze the effects of the morpholino on gli2GFP expression, we tested the highest concentration of gli2MO by western blot analysis of whole embryos protein extract and found that the band intensity was noticeably reduced by the effect of the morpholino (Fig. 2F ). Thus, these two approaches allowed us to confirm the efficiency of gli2MO against gli2 expression.
We subsequently carried out loss-of-functions studies to analyze the requirement of Gli2 in the induction of the NC. gli2MO (27 ng/E) was microinjected into one dorsal blastomere of 8-cell stage embryos together with the lineage tracer fluorescein dextran amine (FDA) to identify the injected side (Fig. 2G ). The analysis of the expression of the NPB markers at stages 13-14 showed that the injection of gli2MO produced a marked reduction in the expression of pax3 ( Fig. 2H , 71%, n = 43), msx1 ( Fig. 2I , 61%, n = 61) and snail1 ( Fig. 2J , 70%, n = 41). This result suggests that gli2 might be required for the early events of NC formation. We then evaluated the participation of gli2 in NC induction by the directed microinjection of gli2 mRNA (2.6 ng/E) in one dorsal blastomere of 8-cell stage embryos. We observed a strong increase in the expression of pax3 (59%, n = 46), msx1 (66%, n = 38) snail1 (72%, n = 39) as shown in Fig. 2K -M. The quantification of the different phenotypes is plotted in Fig. 2N -O. These results reinforce the assumption that gli2 would participate in the early events of NC formation.
NC explant culture provides a way to specifically analyze the effect of certain chemicals exclusively on these cells, thus providing a detailed spatial and temporal control of the experiment. We have previously shown that the inhibition of Ihh signaling by the effect of Cyclopamine produces a decrease in the expression of the NC gene marker foxd3 (Aguero et al., 2012) . Based on these results, we decided to evaluate the function of GANT61, a specific Gli2 inhibitor, in the induction of the NC by analyzing its effects on the expression of the foxd3 marker. GANT61 prevents Gli2 from binding to the DNA, thus precluding its action as a transcription factor (Agyeman et al., 2014; Lauth et al., 2007) . Taking into account that the Gli1 protein is not directly modulated by Hh signaling and that it is not expressed in the NC (Nguyen et al., 2005; Suzuki et al., 2010) , we can assume that the effects of GANT61 on NC are only due to the inhibition of Gli2. Consequently, we performed NC explants containing the underlying mesoderm (NC + M) at stage 12.5 and incubated them with 50 μM GANT61 (or only the vehicle as control) until stage 16, when the explants were fixed and the expression of foxd3 was tested (Fig. 2P ). The inhibition of Gli2 by GANT61 produced a marked decrease in the expression of foxd3 ( Fig. 2Q , 80% of explants n = 35) as compared with DMSO incubation, in which no reduction in foxd3 was detected ( Fig. 2R , 94% of NC + M explants with normal expression, n = 16). To summarize, this combination of approaches to block Gli2 expression and function allowed us to suggest that this transcription factor is important in the early events that regulate NC formation.
gli2 is required for the maintenance of NC specification
After NC induction occurs, these cells are specified and acquire a distinct molecular signature that separates them from other ectodermal cells. In order to assess the requirement for gli2 in NC specification we analyzed the expression of the NC specifier genes foxd3, snail2 and sox9 after experimentally affecting gli2 function (Fig. 3A) . gli2MO injection produced a reduction in the expression of the NC markers foxd3 (64%, n = 66), snail2 (92%, n = 25) and sox9 (46%, n = 13) on the injected side, as indicated in Fig. 3B -D. To assess whether the effects produced by gli2 gain-and loss-of-function on NCC affected the other ectodermal cell populations, we tested the expression of the NP marker sox2 and the prospective epidermis marker xk81a ( Fig. 3E-F) . The results showed that gli2 knock-down produced an increase in the expression of sox2 (45%, n = 69) as well as in the epidermal marker xk81a (74%, n = 15). To assess this phenotype in the same embryo we performed a double ISH of the sox2 and xk81a markers after gli2MO injection. We observed a decrease in the NC territory at the expense of an increase in the expression of the markers sox2 and xk81a ( Fig. 3G , 75%, n = 16). The quantification of the phenotypes is plotted in Fig. 3H . These findings may imply that changes in NC territory are not a product of an increase in cell proliferation but could be due to changes in the ectodermal cell fate instead.
Subsequently, we evaluated the effect of gli2 mRNA overexpression on the same gene markers. Fig. 3I -N show that gli2 gain of function produced an increase in the expression of the NC specification markers foxd3 (56%, n = 81), snail2 (58%, n = 26) and sox9 (53%, n = 19). As might be expected, we found that the overexpression of gli2 produced a concomitant decrease in the expression of sox2 ( Fig. 3L ; 53%, n = 49) and xk81a ( Fig. 3M ; 56%, n = 27). These results were also found when their expressions were analyzed in the same embryo by double ISH (Fig. 3N ; 60%, n = 20). Fig. 3O shows the quantification of the above phenotypes. In order to target the overexpression of Gli2 directly to NCC in a temporally and spatially controlled manner we used the α3000gli2 construct. This plasmid uses the snail2 promoter to specifically direct the expression of downstream constructs to the NC (Vallin et al., 2001) . The specific overexpression of gli2 ( Fig. 3P -Q) caused a clear increase in the expression of the NC markers foxd3 (54%, n = 13) and snail2 (50%, n = 14). To determine whether the effects seen on the NC are a result of the inhibition of the Gli2 function by gli2MO, we prepared a rescue construct, named CRgli2, which encodes the full- length Gli2 protein containing 6 mismatches in the nucleotide sequence recognized by the morpholino. The co-injection of CRgli2 mRNA along with gli2MO efficiently restored the disrupted expression of the markers foxd3 (60% of embryos with normal expression, n = 48) and snail2 (53%, n = 17) in the NC ( Fig. 3R-S) . Moreover, to specifically rescue gli2 function in the NC territory, we coinjected gli2MO along with the α3000CRgli2 plasmid, which carries the mutations in the MO binding site and is additionally transcribed under the snail2-promoter action only during NC specification. This experiment yielded a rescue in the expression of the snail2 marker ( Fig 3T and V, 82% , n = 22). Furthermore, as a control of morpholino toxicity, we injected CoMO and found that the expression of foxd3 was not affected ( Fig. 3U and V, 88%, n = 17). Altogether, these results imply that Gli2 participates in the specification of the NC.
We then tested the pharmacological inhibition of Gli2 function with GANT61 during NC specification using three different approaches. The first one consisted of the injection of GANT61 at a concentration of 3 μM in one dorsal blastomere of 8-cell stage embryos (Stage 3). This low concentration was chosen to avoid possible toxic effects in the injected blastomere. Afterwards embryos were fixed at stage 16 and the expression of the NC markers foxd3 and snail2 was analyzed (Fig. 4A ). The loss of function of gli2 produced a marked reduction in the expression of the NC marker foxd3 ( Fig. 4B and F, 64% n = 11) and snail2 ( Fig. 4C and F, 65%, n = 20) on the injected side. In agreement with the results obtained with gli2MO, the injection of GANT61 produced an increase in sox2 ( Fig. 4D and F, 47%, n = 19) and xk81 expression ( Fig. 4E and F, 50%, n = 8). As a control we injected the diluent of GANT61 (DMSO 0,03%) and analyzed the expression of the above mentioned markers ( Fig. 4G-K ). We found that almost all embryos showed no change in gene expression between the control and the injected side (foxd3, 95%, n = 20; snail2, 95%, n = 22; sox2, 91%, n = 23; xk81a, 95%, n = 21).
The second approach consisted in implanting GANT61-soaked beads into the NPB of stage 12.5 embryos, which were then fixed at stage 16 for the analysis of foxd3 expression ( Fig. 4L ). The pharmacological inhibition of Gli2 produced a marked decrease in the expression of foxd3 on the injected side ( Fig. 4M and O, 57%, n = 37) in contrast to control embryos implanted with DMSO-soaked beads, in which the majority of the embryos presented no change in expression ( Fig. 4N and O, 73% n = 34). Finally, in the third approach we incubated NC explants with the underlying mesoderm in GANT61 from stage 14 to 18, during which the specification of the NC takes place. The results showed a marked decrease in foxd3 expression when NC explants were treated with the inhibitor (Fig. 4Q , 92%, n = 36) while lack of effect was observed in DMSO-incubated control explants ( Fig. 4R , 94% normal expression, n = 36). These results showed that Gli2 is required for the maintenance of the specification of the NC during midneurula stages.
The transcriptional activator form of gli2 acts on NC specification
Our next step in the elucidation of the mechanism of action of Gli2 was to determine which functional form is responsible for eliciting the effects observed in NC induction and specification. It is known that in most cases Gli2 acts as a transcriptional activator (McCleary-Wheeler, 2014), but for some developmental contexts it has been shown that Gli2 might act as a transcriptional repressor (Bowers et al., 2012) . With these facts in mind we prepared DNA constructs encoding functional forms of Gli2 lacking the N-terminal repressor domain (gli2act) and the C-terminal activator domain (gli2rep) in order to discern which functional variant is operating in the NC. These functional constructs of Gli2 have already been tested in other studies and have been found to activate, for the case of gli2act, and to repress (gli2rep) the expression of Hh target genes (Pan et al., 2006; Santos and Reiter, 2014; Sasaki et al., 1999) . The summarized experimental procedure is indicated in Fig. 5A . The directed microinjection of the activator form of gli2 (gli2act) produced an increase in the expression of the NC markers foxd3 (Fig. 5B , 56%, n = 32) and snail2 ( Fig. 5C , 72%, n = 28). Moreover, gli2act was also able to rescue the phenotype of the gli2MO-injected embryo (foxd3, Fig. 5D , 45%, n = 51; snail2, Fig. 5E , 67%, n = 15). Additionally, the NC-specific overexpression of the α3000gli2act construct rescued the morphant phenotype, producing an increased expression of foxd3 ( Fig. 5F , 75%, n = 16) and snail2 ( Fig. 5G , 60%, n = 15). Secondly, we tested the action of the repressor form of Gli2 (gli2rep). We found that gli2rep produced a consistent reduction in the expression of the markers foxd3 ( Fig. 5H , 78%, n = 70) and snail2 ( Fig. 5I , 59%, n = 54), indicating an inhibition of the specification of the NC. Therefore, as expected, the coinjection of gli2rep along with gli2MO produced no rescue in foxd3 ( Fig. 5J , 62% of embryos showing reduced foxd3 expression, n = 16) and snail2 expression ( Fig. 5K , 53% reduced snail2 expression, n = 30). The quantification of these phenotypes is indicated in Fig. 5L . These results strongly suggest that the transcriptional activator function of Gli2 is essential for the specification of the NC.
In the canonical signaling, when the Hh pathway is inactive, Gli2 processing takes place as a result of multi-site phosphorylation at six conserved serine residues that occurs due to the sequential action of the kinases PKA, CK1 and GSK3β. This phosphorylated version of Gli2 is ultimately processed by the proteasome and a large proportion of the protein pool is degraded, with the remaining part of the Gli2 protein acting as a transcriptional repressor (Pan and Wang, 2007) . Conversely, when the Hh signal is present, the phosphorylation by PKA is prevented and therefore Gli2 is converted into a transcriptional activator (Niewiadomski et al., 2014; Riobo et al., 2006; Tuson et al., 2011) . Accordingly, we created a mutant version of Gli2 in which the six PKAtarget serine residues were changed into non-phosphorylatable alanine residues, thus acting as a constitutive transcriptional activator when expressed in Xenopus embryos. This protein, unable to be phosphorylated and degraded, was called gli2PSM (gli2-PKA Site Mutation). The overexpression of this construct produced a marked increase in the expression of the markers foxd3 ( Fig. 5M and Q, 51% n = 55) and snail2 ( Fig. 5N and Q, 60%, n = 15), whereas it reduced the expression of sox2 ( Fig. 5O and Q, 59%, n = 17) and xk81a ( Fig. 5P and Q, 61%, n = 18). In addition, we overexpressed this construct in a NC-specific fashion through the injection of the plasmid α3000CRgli2PSM and found that it increased the expression of foxd3 ( Fig. 5R , 73%, n = 22). Moreover, this construct was able to rescue foxd3 and snail2 expression after gli2MO injection ( Fig. 5S -T, foxd3 81%, n = 16; snail2 64%, n = 14). The quantification of these experiments is shown in Fig. 5Q and U.
In summary, the results provide compelling evidence for a role of gli2 in the maintenance of the specification of the NC. In addition we also found that the transcriptional activator form could be the active variant participating in NC specification.
gli2-mediated transcriptional activation modulates the expression of NC and NPB specifiers
To further explore Gli2 role on NC development we studied the specific mechanism through which Gli2 exerts its function during NC specification. We analyzed the transcriptional activity of Gli2 using a Gli-dependent genetic reporter construct known as the 8xGBS-Luciferase plasmid (8xGBS-LucII; GBS, specific Gli Binding Site) (Sasaki et al., 1997) . Embryos were injected in both dorsal blastomeres at stage 3 with the reporter plasmid (8xGBS-LucII) along with an internal control plasmid (pGL4.74-TK-hRluc, Promega, USA). These luciferase reporter constructs were coinjected with different in vitro-transcribed mRNAs and MOs in order to assess the effect of Gli2 on the transcriptional response of the reporter construct. For maximal tissue specificity and spatio-temporal control we dissected out NC explants for the luciferase assay. At stage 15-16 NC explants were dissected out and the firefly luciferase activity was assayed and normalized to the Renilla luciferase activity using a commercial kit (Dual-Luciferase Reporter Assay System, Promega, USA). The scheme of this experimental design is shown in Fig. 6A . The injection of either gli2 or ihh mRNA produced a significant increase in Luciferase expression ( Fig. 6B ). By using a mutated version of the 8xGBS domain (8xGBSmut-LucII plasmid) along with the coinjection of gli2 mRNA (2.6 ng/E), we found that the increased Luciferase activity produced by Gli2 overexpression was abolished. This result indicates that the increase observed in Luciferase activity was only due to a stimulation of the 8xGBS promoter caused by Gli2. On the other hand, when we knocked down gli2 and ihh function with their respective MOs, a marked reduction in Gli-mediated Luciferase activity was observed. These results allow us to suggest that Gli2 acts as a transcriptional activator in the development of Xenopus NC.
In order to determine whether gli2 was acting downstream of ihh in the gene regulatory network that participates in NC specification, we injected gli2 mRNA and ihhMO and observed that Gli2 was able to rescue the Luciferase expression back to the control levels. Additionally, we coinjected ihh mRNA and gli2MO and found that the ihh-increased Luciferase activity was markedly reduced. However, a small activation of the luciferase reporter still persisted, suggesting that other players could also act on the reporter construct in response to ihh stimulation. We speculated that Gli3 in particular could play this role in the activation of the 8xGBS promoter. We also decided to analyze the effect that the constitutive transcriptional activator form of Gli2, gli2PSM, elicits during NC specification. We observed that Luciferase activity increased up to eight times compared to Renilla luciferase activity. This indicates that the effects of gli2PSM injection on the expression of the NC markers shown in the previous section were produced by the transcriptional activator function of the protein encoded by this mRNA. Finally, we observed that Gli2 inhibition by GANT61, produced by the incubation of NC explants from stage 13 to 16 with this inhibitor, caused a small, nonsignificant reduction in Luciferase activity with respect to the control embryo. Altogether, our results strongly point to a mechanism in which Gli2 stimulates the transcription of target genes during the development of Xenopus NC.
The expression of many genes must be tightly regulated for NC to develop properly. As noted previously, these genes are included in groups called NPB specifiers, NC specifiers and effector genes (Sauka-Spengler and Bronner-Fraser, 2008) . To further investigate whether gli2 is involved in regulating the expression of such genes we performed quantitative RT-qPCR analysis of NC explants that were injected with either gli2MO or gli2 mRNA. The specific genes analyzed were the NPB specifiers pax3, hairy2b and snail1, the NC specifiers snail2 and twist, and also the cell adhesion genes e-cad and n-cad. In this qPCR analysis gapdh was used as loading control. Embryos were injected in both dorsal blastomeres at stage 3, and at midneurula stages (st. 14-16) 200 NC explants were dissected out and the total RNA was extracted and analyzed by RT-qPCR. (Fig. 6C ). This gene expression analysis performed on the NC tissue showed the effect of gli2 specifically on NC development (Fig. 6D ).
Regarding the expression of the NPB markers, we found that in the case of pax3, hairy2b, and snail2 the morpholino knock-down of gli2 produced a significant reduction in their expression, whereas the gain of function by overexpression of this gene increased the expression of these markers, with snail1 showing the higher increase in expression of the NPB genes analyzed. This analysis also showed that gli2 is required for their expression. The expression of the NC specifiers snail2 and twist, also showed a functional interaction with gli2 similar to the one found for the NPB genes, and twist1 was the most sensible gene to gli2 gain of function, showing a 14-fold increase in its expression, compared to the uninjected wildtype NC. Finally, in the case of the cell adhesion genes, we found that e-cad and n-cad were downregulated when the gli2 function was knocked down. Only n-cad increased its expression after gli2 injection, suggesting a positive regulation of gli2 of its expression.
2.6. gli2 is involved in the control of apoptosis of NCC but not in their proliferation
The above results suggest that gli2 might act on NC development by changing cell fate. However, we considered the possibility that this protein could participate in the apoptotic process or in the cell proliferation of NC during the specification period. In order to determine whether gli2 participates in cell proliferation we performed an IHC assay in which we analyzed changes in cell proliferation when we knocked down or overexpressed the gli2 gene. The detection of proliferating cells was made by IHC against phospho-histone H3, which is present in cells undergoing mitosis. Our results showed that there were no significant changes in the number of proliferating cells between the injected and the control sides of embryos (n = 8) for gli2MO or gli2 mRNA-injected embryos ( Fig. 7A-C) . These results show that gli2 is not involved in the proliferation of the NCC during their induction and specification.
We also tested whether the effects of gli2 function on NC were due to changes in the apoptotic process. We injected either gli2 mRNA or gli2MO in the dorsal blastomeres of 8-cell stage embryos, grafted NC explants at mid neurula stage (n = 20) and measured the caspase 3/7 activity with a homogeneous assay ( Fig. 7D , see Materials and Methods). The overexpression of gli2 produced a 2.5-fold reduction in caspase activity. This suggests that gli2 specifically plays a role in the apoptotic state of the NC. On the other hand, the injection of gli2MO had no effect on the apoptosis level of NCC. To further validate the specificity of gli2MO we coinjected it with CRgli2 and found that the apoptotic level of the NC was also reduced, similarly to gli2 overexpression. We also tested the ability of the gli2 activator construct (gli2act) to control apoptotic levels, and found out that it reduced caspase activity levels even when we coinjected it with gli2MO ( Fig. 7E) . These results suggest that the mechanism of action of Gli2 in NC specification might not be due to the regulation of the proliferative state of NCC, but that it may prevent cells from undergoing apoptosis, thereby maintaining their survival during mid-neurula stages.
gli2 is required for the proper migration of NC in a cell-autonomous process
Migration of the NC is an essential process that allows these cells to colonize several regions of the embryo. Once the NC is already specified, effector proteins induce epithelial-to-mesenchymal transition (EMT), delamination, and finally migration of the NCC. We employed different strategies to determine the participation of gli2 in Xenopus NC migration, using gli2MO and the spatio-temporal control of GANT61 inhibitory action through soaked-beads grafting. The first approach consisted in the targeted injection of gli2MO along with different gli2 constructs in a dorsal blastomere of stage 3 embryos, and the assessment of NC migration at stages 20-22 (Fig. 8A) . The loss of function of gli2 caused a reduction in the expression of foxd3 between the control side and the injected side ( Fig. 8B, 63%, n = 16 ). This result was confirmed by the analysis of sox10 (Fig. 8C , 70% n = 33). We then determined the rescue of gli2 function by coinjecting CRgli2 and gli2act along with gli2MO. The results show that these mRNAs were able to (caption on next page) restore the front of migration of NC as evidenced by foxd3 expression (Fig. 8D, gli2CR , 69%, n = 26; Fig. 8E, gli2act, 50%, n = 14) .
Subsequently, we knocked down gli2 function through the injection of the pharmacological inhibitor GANT61 at a concentration of 3 μM. We found that GANT61 produced a marked reduction in the front of migration of the NC as evidenced by the diminished expression of foxd3 (Fig. 8G, 56% n = 16) . We next evaluated the function of Gli2 in NC migration in a more spatio-temporal specific manner. We implanted GANT61-soaked beads into the NC of embryos at two time frames ( Fig. 8I and L) . The first time frame comprised the stages of specification maintenance and onset of migration (stages 14-22). Here we observed a marked reduction in the front of migration in the treated side, as shown by the expression of sox10 (Fig. 8K , 56% n = 43). Treatment with DMSO did not produce any significant changes ( Fig. 8J, 93% , n = 28). This indicates that if gli2 is not properly functioning at the NC maintenance of specification period, NC migration is affected. The second experiment analyzed gli2 knockdown from stages 17 to 22. In this case GANT61 inhibition was performed at the beginning of NC cell migration and the results showed an impaired cell migration in the implanted side of the embryos (Fig. 8N, 62% , n = 45). As expected, DMSO treatment produced no changes in the front of migration (Fig. 8M, 89% , n = 37). Altogether, being that in this particular assay Gli2 was interfered during the onset of migration, we can conclude that gli2 is involved in the process of NC migration.
The process of NC migration is complex, with different signals acting coordinately to trigger the EMT in NCC along with a change in the cadherin molecular signature. We previously found that the Ihh signaling pathway is essential for NC migration (Aguero et al., 2012) . Therefore, we decided to further explore the requirement of gli2 in this process. To that end, we knocked-down gli2 function by the microinjection of gli2MO, grafted NC explants at stages 17-18 into WT siblings and then analyzed NC migration under fluorescence microscopy following the FDA lineage tracer (Fig. 8P) . Initially, we grafted uninjected NC control explants into wild type embryos. This produced a normal NC migration pattern in the host embryo as evidenced by the analysis of FDA fluorescence (Fig. 8Q, 67% , n = 18). When NC explants from embryos injected with gli2MO were grafted into wild type embryos, migration was severely affected (Fig. 8R, 64% , n = 11). Conversely, when uninjected NC explants were grafted into gli2MO-injected host embryos, migration was normal, undistinguishable from the untreated NC explants grafted into WT embryos (Fig. 8S, 60% , n = 10). These results show that gli2 acted in a cell autonomous manner in NCC migration, as this process only depends on proper gli2 function in the NC and not on external signals that could also depend on the function of gli2.
gli2 is required for the development of NC derivatives
In order to further explore the role of gli2 on the development of the NC, we investigated the effect of gli2 knockout on NC derivatives. Embryos were injected with gli2MO, GANT61 or with a combination of rescuing constructs at stage 3 and then, at stage 45, the analysis of cartilage morphology was performed by Alcian Blue staining ( Fig. 9A-B ). The injection of GANT61 produced a slight reduction in the size of the cartilages (52%, n = 27, Fig. 9C ). Interestingly, gli2MO-injected embryos showed a severe reduction in the size of the craniofacial cartilages in the injected side ( Fig. 8D, 71%, n = 21) . The gross morphology of craniofacial cartilages revealed that NC-derived cartilages (Meckel's, ceratohyal, and mostly the ceratobranchial cartilages) were severely reduced. The coinjection of CRgli2 was able to rescue the morphant phenotype, thereby proving the specificity of the gli2 function on NC derivatives formation (Fig. 8E, 67% , n = 21). As a control we injected CoMO and found no effect on craniofacial cartilage size or morphology (Fig. 9F, 100% n = 30) , indicating that the observed effect was only due to gli2 loss of function. The quantification of the embryos is shown in Fig. 9G .
With the purpose of analyzing the role of gli2 in the development of craniofacial cartilages in a more temporally and spatially controlled manner, we grafted two GANT61-soaked beads into the NC region of embryos either at stage 12.5 or 17 and analyzed their cartilage morphology at stage 45 ( Fig. 9H-M) . In both treatments, the structure and size of the craniofacial cartilages were severely disrupted in the grafted side ( Fig. 9J and N, st. 12.5-45 with GANT61, 59%, n = 29; Fig. 9M and N, stage 17-45 with GANT61, 63%, n = 24), in contrast to the embryos implanted with DMSO-soaked beads ( Fig. 9I and N, st. 12.5-45, 89% normal, n = 28; Fig. 9L and N, st.17-45, 93% normal, n = 28). However, taking into account the fact that we affected Gli2 function during the beginning of NC migration, we cannot decisively conclude that the impairment of derivative formation was due to a deficit in NC migration or in the differentiation process. Therefore, future experiments are needed to address this issue.
NCC are also responsible for the formation of different kinds of pigmented cells in the vertebrate body (Lapedriza et al., 2014) . To further investigate the effects of gli2 in the formation of NC derivatives we analyzed the role of gli2 in melanocyte development. We found a remarkable decrease in melanocyte number at stage 36 in the injected side, suggesting a strong participation of gli2 in the development of this cell type ( Fig. 9O-Q, 68% , n = 22). We also decided to evaluate the effect of gli2MO in the formation of Rohon-Beard (RB) sensory neurons and glia precursors, which in Xenopus laevis are marked by the expression of the tbx2 gene (Takabatake et al., 2000b) . The results indicate that gli2 loss of function produced a reduction in these cell populations ( Fig. 9R -T′, 69%, n = 13). tbx2 expression also allowed us to conclude that, in the cranial region of the embryo, gli2MO produced a severe reduction in the trigeminal, the profoundal and the lens placodes. This suggests that gli2 might participate in cranial ganglia primordia formation. Taken together, these results suggest that gli2 is involved in the development of NC derivatives, namely craniofacial cartilages, melanocytes, RB neurons and cranial ganglia precursors.
Hierarchical relationships of gli2 in early NC development
To assess the function of Gli2 in the gene regulatory network that is essential for the formation of the NC, we analyzed its hierarchical relationships with other components of the Hh signaling pathway as well as with other genes involved in NC development. We have previously shown that the Ihh ligand is essential for the development of the NC during early Xenopus development (Aguero et al., 2012) . Consequently, we set out to analyze the particular hierarchical relationship between gli2 and the ihh gene. Stage 3 embryos were injected with ihh or coinjected with gli2MO and ihh mRNA, and the expression of foxd3 was analyzed. Ihh overexpression alone produced an increase in the expression of foxd3 ( Fig. 10B, 72% , n = 50), whereas the knockdown of its function decreased the expression of foxd3 (Fig. 10C, 73% , n = 51) (Aguero et al., 2012) . The combination of ihh and gli2MO blocked the effect of the ihh overexpression and produced a strong reduction in NC population (Fig. 10D, 75% , n = 20), whereas the opposite combination, i.e., ihhMO and gli2 mRNA, rescued the phenotype produced by the lack of ihh (Fig. 10E, 75% , n = 28). This result suggests that gli2 acts downstream of ihh in the signaling cascade in Xenopus laevis early NC development.
Additionally, we evaluated the epistatic relationship between gli2 and gli3. The overexpression of gli3 mRNA caused an increase in NC territory (Fig. 10F, 81% , n = 70). Moreover, knocking down gli3 function diminished foxd3 expression ( Fig. 10G, 75% , n = 60). When we coinjected gli2 mRNA along with gli3MO, we observed a remarkable rescue in the expression of the NC marker foxd3 (Fig. 10H, 69% , n = 16). On the other hand, when we coinjected gli2MO along with gli3 mRNA, we also observed a rescue of gli2 function manifested in the rescue of the expression of the NC marker foxd3 (Fig. 10I, 55% , n = 40). This might be indicative of a possible redundancy in the function of both genes during the gene regulatory network that forms the NC.
We also studied the epistatic relationship between gli2 and the ednra gene. Ednra signaling is required for early NC development, as the modulation of its functions affects foxd3 expression in the NC (Fig. 10J-K, (Bonano et al., 2008) ). In particular, overexpression of ednra causes an increase in foxd3 expression ( Fig. 10J, 65% , n = 40), while its knockdown reduces the expression of this NC marker (Fig. 10K, 73%, n = 70 ). In the epistatic analysis, when ednra mRNA was coinjected with gli2MO, no rescue of foxd3 expression was observed (Fig. 10L, 63% n = 41) . Conversely, gli2 overexpression was able to rescue the reduced foxd3 expression in embryos treated with ednraMO ( Fig. 10M, 69% n = 59) . This combinatorial analysis allowed us to suggest that gli2 acts downstream of the ednra gene during NC induction and specification.
Finally we sought to establish the relationship between gli2 and the kinesin Eg5, which has been previously shown to participate in the processes that regulate the development of the NC (Fig. 10N-O , Fernandez et al., 2014) . We observed that the overexpression of eg5 mRNA produced a marked increase in the expression of foxd3 (Fig. 10N , 77%, n = 60). On the other hand, when we injected eg5MO, foxd3 expression was reduced ion the injected side ( Fig. 10O, 85% , n = 40). We then proceeded to the epistatic assays. The coinjection of eg5 mRNA could not rescue foxd3 expression produced after gli2 knockdown ( Fig. 10P and R, 66% of reduced expression, n = 29). Conversely, gli2 mRNA coinjected along with eg5MO produced a striking rescue in the expression of foxd3 ( Fig. 10Q and R, 70% n = 10). Therefore, gli2 might act downstream of eg5 during NC specification.
In summary, in this section we showed that gli2 is downstream of several genes that are important during NC development, indicating that these genes may possibly interact in order to establish the molecular framework for the development of the NC. The proposed model for the epistatic interactions of gli2 and these genes is shown in Fig. 10S .
Discussion
NC formation involves a complex network of molecular actors, i.e., receptor/ligand-signaling systems that translate environmental cues to specific molecules into the cell to control cellular behavior. Gli2 is a key transcription factor during vertebrate development and is also indispensable for the maintenance of homeostasis in the adult organism. Additionally, a misregulation of its function has been shown to cause a wide array of different congenital diseases and many types of cancers (McCleary-Wheeler, 2014) . Therefore, it is crucial to understand the regulation of Gli2 and its function in different developmental processes in order to unveil its mechanisms of action and for the development of novel therapeutical molecules and treatments. In this study, we investigated gli2 requirement in NC development through different molecular, pharmacological and embryological approaches. We found that Gli2 is a key regulator of early embryogenesis required for NC induction, specification, migration and differentiation acting as a transcriptional activator.
The onset of NC specification occurs during late gastrulation (Stuhlmiller and García-Castro, 2012) . We found that gli2 was expressed in the NPB and NC from late gastrulation onwards, undoubtedly indicating a role in the early events that define the NC population and the later processes required for its migration. Thus, this study provides an extensive analysis of the gli2 expression pattern that complements previous analyses (Aguero et al., 2012; Michiue et al., 2017; Perron et al., 2003; Rankin et al., 2016) . Moreover, we independently analyzed Ptch1 expression by wholemount IHC. The product of ptch1 gene, a well-known target of Hh signaling, was found in the NC territories during neurulation in expression domains fully compatible with a role in the early NC developmental processes. These results are in agreement with previous findings that partially showed ptch1 expression (Rorick Takabatake et al., 2000a) , and with its use as a readout of Hh activity in the neural fold (Aguero et al., 2012) . Recently, a comprehensive transcriptome analysis of ectodermal dissected regions from Xenopus embryos was made available through a searchable tool called EctoMap (Plouhinec et al., 2017) . The gli2 and Ptch1 expression patterns described here were compared with this database and we found that the gli2 L-homeologous has a higher relative expression and is the one that most closely resembles the expression pattern found in this study using ISH in the NC at neurula stages. Moreover, ptch1 expression in EctoMap recapitulates the expression found in this work. Taken together, these results strongly support a role for gli2 in the NC.
On the other hand, our expression pattern found gli2 transcripts in the anterior NP throughout neurulation, which coincides with the role of gli2 as an essential factor in the development of the telencephalon, and as a causative factor for holoprosencephaly when it is mutated (Roessler et al., 2003; Takanaga et al., 2009 ). During vertebrate development, NCC are essential for the formation of ocular tissues such as the corneal endothelium, the corneal stroma and the sclera (Evans and Gage, 2005; Williams and Bohnsack, 2015) . The expression of gli2 in the optic territory during tailbud stages concurs with the role of NC in ocular development, and also agrees with the role that Hh plays during the development of Xenopus retinal pigment epithelium (Perron et al., 2003) . Finally, gli2 was also detected in the developing somites, which is consistent with the fact that gli2 is a direct target of the myogenic regulatory factor myoD in Xenopus development (McQueen and Pownall, 2017) .
NC induction is a complex multi-step process involving many diffusible molecules, signaling pathways and transcription factors that interact to shape the specification and identity of NPB cells in order for them to become NC-fate restricted cells. Here, we provide evidence that gli2 is required for the expression of a subset of these genes in the early specification steps. This fact puts gli2 in a pivotal position during the initial steps that give ectodermal cells the NPB identity. We also corroborated the timing of gli2 requirement in NC induction through two approaches using the specific inhibitor GANT61. The NPB genes particularly affected by gli2 gain-and loss-of-function include pax3, msx1, snail1, zic3 and zic5 Groves and LaBonne, 2014; Monsoro-Burq et al., 2005; Nakata et al., 2000; Nakata et al., 1997; Tribulo et al., 2003) . Moreover, by a RT-qPCR assay of NC explants, we found that gli2 is required for the expression of NPB specifiers genes pax3, hairy2b and snail1 Vega-Lopez et al., 2015) . These findings support a role for gli2 in the early steps of NC development.
Once the NPB territory is competent to become NC, additional signals are integrated to maintain NC specification. These factors are called NC specifiers and are crucial in establishing NC identity (Duband et al., 2015; Pegoraro and Monsoro-Burq, 2013) . Moreover, they are important for the EMT transition and the subsequent migration of NCC. We scrutinized the role of gli2 in this process through microinjection and NC-explant assays and found that it modulates the expression of key NC specifiers. We found by qPCR analysis that gli2 regulated the expression of the NC specifiers snail2 and twist1, confirming the role of gli2 in the specification process of the NC. It could be argued that gli2 might indirectly control the expression of these genes by initially controlling the expression of the NPB specifiers, and then these genes would take over the activation of the NC specifiers. However, considering that NC induction does not fully confer a certain fate to NPB cells but enables them to respond to other signaling cues, acting as progenitor cells (Roellig et al., 2017) , it is possible that gli2 input is indeed necessary for both processes in a direct way. However, it remains to be determined whether gli2 acts in this fashion by directly binding to promoters of some NC specifiers to control the specification of the NC. NC transcription factors operate by activating or repressing the expression of their target genes. Gli2 could act as a transcriptional activator or repressor depending on the particular status of the Hh signaling (Ruiz i Altaba et al., 2007) . We designed and constructed different functional variants to assess which form of gli2 participates in NC development. We found that the activator form of Gli2 is responsible for the induction and specification of the NC, as evidenced by the transcriptional responses of foxd3 and snail2 marker genes. Additionally, we found that the repressor form of gli2 reduced the expression of such markers. Moreover, the gli2PSM construct, which lacks the phosphorylation sites for PKA and behaves only as a transcriptional activator, also increased the NC markers expression during initial specification. Additionally, by performing a Gli-dependent luciferase activity assay on NC explants, which uses 8 tandem Gli-binding sites driving the luciferase construct, we confirmed that Gli2 acts as a transcriptional activator during NC development. Different combinatorial experiments on NCC showed that gli2 responds to ihh for the proper activation of its target genes. Interestingly, the injection of the gli2PSM construct produced a dramatic increase in the expression of the reporter construct, thereby confirming the activator role of Gli2 during NC morphogenesis. Altogether, our results point to the fact that this transcription factor acts as an activator to specify the NC. These results extend the current insights of Gli2 functions in embryogenesis, specifically during NC development.
Gli2 is expressed in the NP and, as shown here, also in the NPB and the neural fold, and is essential for the D-V patterning of the NP through the control of several specific genes (Pal and Mukhopadhyay, 2015) . The fact that the same molecule can control the expression of different genes in contiguous territories suggests that this transcription factor responds differently in each cell population. With respect to this question, one possibility could be argued in favor of the Hh ligand that stimulates the pathway. Based on our previous expression pattern and the functional analysis the Gli2 protein, we postulate that this protein receives the signal from the Ihh ligand in the NC, and not from Shh secreted from the notochord and the floor plate (Aguero et al., 2012) . Secondly, the differential activity of Gli2 between the NC and the NP could be explained by proposing that NC-specific expression of regulatory proteins and transcription factors present in the NC tissue creates a differential context for the action of Gli2. During NC development, one possible candidate for the differential action of Gli2 could be Pax3, one of the NC earlier specifiers (Monsoro-Burq et al., 2005) , which has been shown to specifically interact with the Hh effector to promote the activation of gene enhancers in the epaxial somite, where both are coexpressed (Himeda et al., 2013) . Additionally, by qPCR we have corroborated the effect of gli2 on pax3 expression. Moreover, other NC-expressed genes have Gli binding sites in their regulatory sequences. This is the case with snail1 and twist1, which are essential for NC specification and are upregulated by Hh during cancer initiation (Kong et al., 2015) . These genes were also tested by qPCR and found to be regulated by gli2. Therefore, our results establish a novel model for further investigations to elucidate the mechanism of action of the Ihh/ Gli signaling during NC development. Additionally, we can conclude that the importance of Gli2 during development is thus not restricted only to the patterning of the neural tube, but extends to the transcriptional activation of NC inductors and specifiers during the morphogenesis of this cell population.
The NC maintains a coordinated balance between proliferation and apoptosis for the proper organization of the derived tissues and for its migration (Le Douarin et al., 2004) . Previous investigations in mice have shown that Shh and Ihh increase the proliferation of NC during the differentiation of its derivatives (Everson et al., 2017; Yang et al., 2016) . Gli2 in particular has been involved in the enhancement of proliferation during lung development by increasing the expression of Cyclin-D (Rutter et al., 2010) . In this work we assessed whether this behavior of gli2 applies to the development of Xenopus NC and found that, in agreement with previous investigations on the role of ihh, gli2 did not alter the proliferative status of the NCC (Aguero et al., 2012; Tribulo et al., 2003) . These findings suggest that the changes observed in the ectodermal marker expression could be due to cell fate decisions operating during gli2 gain-and loss-of-function.
On the other hand, we found a marked reduction in the apoptotic state of NCC when gli2 or its activator form was overexpressed. These results correlate with the proven role of the Hh signaling pathway in the survival of the NCC in chick and mouse models (Delloye-Bourgeois et al., 2014; Smoak et al., 2005) . Moreover, in carcinoma cells, Gli2 elicits this function through the transcriptional upregulation of the prosurvival gene cflip (Kump et al., 2008) . Gli2 has also been shown to promote cell survival and to interact directly with pax3 as mentioned before (Himeda et al., 2013; Wang et al., 2011) . Curiously, pax3 is one of the transcription factors operating in NC development, suggesting that the interaction between both genes could be crucial for the survival of NCC.
NC migration occurs shortly after the cells have performed the EMT and become delaminated from the dorsal side of the embryo (Kerosuo and Bronner-Fraser, 2012; Kuriyama and Mayor, 2008) . Cadherins in particular are important during the cell-cell interactions that trigger the migratory behavior of NCC (Taneyhill and Schiffmacher, 2017) . One of the changes that are needed for NCC to become migratory involves the dissolution of tight cadherin-mediated adherens junctions. Our quantitative qPCR data showed that gli2 overexpression actively increases the expression of e-cad and n-cad, which are known to be upregulated during the initial phase of NC migration (Cousin, 2017; Huang et al., 2016) . This regulation highlights the role of gli2 as a regulator of NCC delamination and migration. Moreover, we have shown that gli2 is required for NC migration in a cell autonomous manner. This data is in agreement with the cell autonomous role that gli2 plays in the proliferation and contact inhibition of cancer cells (Alexaki et al., 2010; Regl et al., 2004) .
In most animal species, cranial NCC form the majority of the craniofacial skeleton (Schilling and Le Pabic, 2014) . Defects in the craniofacial apparatus underlie some of the most common human birth defects such as cleft palate, in which Hh signaling plays a central role (Xavier et al., 2016) . Moreover, Gli2 has been associated with the formation of mouse temporomandibular joint articular disk (Purcell et al., 2009) . Therefore it is of crucial importance to understand the factors that promote the skeletogenic differentiation of cranial NCC in order to elucidate the mechanisms that drive human birth defects. In this work we strongly related gli2 function with the development of the craniofacial cartilages, which agrees with its role in proliferation and differentiation of chondrocytes (Joeng and Long, 2009; Thompson et al., 2017) . The abnormal development of the craniofacial cartilages produced by interfering with Gli2 function may reflect a deregulation of the processes that control NC formation and the subsequent NCC migration. A probable mechanism of this process could be the direct action of Gli2 upon sox9 to promote or regulate the chondrocytic lineage, as it is known that both proteins interact in cancer cells (Syu et al., 2016) .
Melanocytes, which are derived from the NC, are formed at all axial levels and are responsible for the pigmentation of the skin and hair follicles (Mort et al., 2015) . Our results indicate that gli2 is involved in the formation of this cell lineage. Considering how gli2 affected sox10 expression in our explant assay, we can argue that the effect observed on the number of melanocytes could be due to a downregulation of sox10, which is a known promoter of the melanocytic lineage (Aoki et al., 2003; Honoré et al., 2003) .
NCC give rise to the cranial ganglia precursors, to all Schwann cells and to the sympathetic neurons of the peripheral nervous system (Newbern, 2015; Sakaue and Sieber-Blum, 2015) . We found that gli2 was required for the formation of the Rohon-Beard sensory neurons and cranial ganglia precursors (in lens, the profoundal and the trigeminal placodes), and for tbx2 expression during the early tailbud stage. tbx2 gene is expressed and required for the formation of the cranial ganglia precursors of the PNS glial cells (Takabatake et al., 2000b) and was found to be regulated by a Gli-dependent Hh signal transduction pathway during Xenopus eye development (Takabatake et al., 2002) . Another possible mechanism that could explain the reduction in Rohon-Beard neurons could be the direct modulation of the expression of ascl1 (Voronova et al., 2011) , which participates in the establishment of the enteric nervous system circuitry, by itself or by repressing the function of sox10 (Kim et al., 2003; Memic et al., 2016) . It is also possible that Gli2 is directly affecting sox10 expression, as this protein has also been shown to be essential for the development of the Rohon-Beard neurons (Olesnicky et al., 2010) . However, since when analyzing the formation of NC derivatives we knocked down gli2 during the migration of the NC, we cannot definitively rule out a role of an altered NC migration in the formation of the NC derivatives.
Our results, integrated with previous studies, support a model in which gli2 acts downstream of the ihh signal secreted from the NC and from the underlying mesoderm to modulate the expression of different NC essential factors. This assumption was confirmed by the luciferase assay, in which we showed that gli2 responds to ihh to activate the transcription of the reporter. Additionally, in our epistatic analyses we found that gli2 and gli3 might act in an equivalent hierarchical position during the induction of the NC. On the other hand, our results have shown that gli2 acts downstream of the receptor ednra during NC specification, and is probably responsible for the action of the Edn1/Ednra signaling in promoting the cell survival of NCC during their specification (Bonano et al., 2008) . Alternatively, a relationship between both signaling pathways could operate in the NC. This positive regulation between Hh and Endothelin-2 signaling pathways was established during the onset of basal cell carcinoma (Tanese et al., 2010) . Additionally, our last epistatic analysis showed that eg5 acts upstream of gli2. Since Eg5 is considered an essential kinesin during microtubule organization and stability (Chen et al., 2017) with a participation in NC development different from its classical function in cell division (Fernandez et al., 2014) , it is conceivable that Eg5 could act in the process required for Gli2 translocation to the primary cilium of Xenopus NCC. Moreover, this kinesin is highly expressed in glioblastoma cells as it is the case of Gli2 (Taglieri et al., 2017) . However, future studies will be needed to specifically pinpoint the interactions between Gli2 and the proteins Eg5 and Ednra during NC development. Our data hence support a model in which Gli2 acts downstream of the Ihh signaling pathway and also responds to the activities of the Ednra signaling and the kinesin Eg5 during the initial steps required for NC formation.
As stated above, an improper specification, migration or differentiation of the NC can result in a group of diseases called neurocristopathies (NCP), which affect an appreciable percentage of newborns (Vega-Lopez et al., 2018) . It has been shown that ciliopathies, which arise due to defects in the assembly or function of the primary cilia, are linked to NCP due to similar craniofacial defects occurring in some specific ciliopathies and NCP (Chang et al., 2015; Vega-Lopez et al., 2018) . However, the genetics and cellular pathogenesis linking NCP and ciliopathies are still incompletely understood. Therefore, it is essential to develop suitable experimental model systems to gather more insights into the molecular basis underlying both diseases. Since gli2 was found to be expressed in the NC and since this transcription factor acts through primary cilia to activate target genes (Eggenschwiler and Anderson, 2007) , we could speculate that this study will improve our understanding of the close relationship between ciliopathies and NCP. Moreover, this approach represents an excellent model to investigate the pathogenesis of NCP during development. Additionally, to the best of our knowledge, this work represents the first embryological usage of GANT61 for inhibiting in vivo the transcriptional activity of Gli2 and thus exploring its role during Xenopus development. Therefore, the use of this inhibitor could prove to be a useful tool for future studies. Altogether, our findings shed new light on the signal-mediated control of NC development by Ihh/gli signaling, and establish Gli2 as an essential factor in the development of the NC. Further investigations on gli2 function and its close relationships with other signaling pathways during Xenopus NC development will improve our understanding of the regulatory mechanisms driving the formation of the NC.
Material and methods
Embryonic manipulation, RNA microinjection and lineage tracing
Embryos were obtained by standard procedures and staged according to the Nieuwkoop and Faber series (Nieuwkoop, 1967) . Tissue microdissections, mRNA in vitro synthesis, microinjection and lineage tracing were performed as previously described (Aguero et al., 2012; Bonano et al., 2008; Fernandez et al., 2014; Vega-Lopez et al., 2015) . In vitro transcribed mRNA was synthesized from pCS2 + 6MT_gli2 (a gift from Muriel Perron, also known as XGli4 (Genbank U42462, (Marine et al., 1997) ) by standard procedures. Lossand gain-of-function experiments through microinjection were conducted as follows: one dorsal blastomere of an 8-cell stage embryo (stage 3) was injected with mRNAs or antisense morpholino oligonucleotides (MO) at different concentrations (expressed as nanograms per embryo: ng/E) along with a lineage tracer, with the uninjected side serving as an internal control. At the desired stage the embryos were fixed with MEMFA and processed by ISH, IHC or another protocol specified in the text.
GANT61 treatment, morpholino antisense oligonucleotides and DNA constructs
In order to specifically inhibit the function of the Gli2 transcription factor in Xenopus laevis NC explants or whole embryos, the inhibitor GANT61 (Medchemexpress LLC, Princeton, NJ, USA) was used to microinject Xenopus laevis embryos and also to incubate NC explants. For incubation experiments, the NC explants with underlying mesoderm were dissected as previously described (Aguero et al., 2012) . In order to spatially control Gli2 function, heparin-sepharose beads (Affi Blue Beads, Bio-Rad, USA) were soaked into 50 μM of GANT61 and grafted into embryos as previously described (Fernandez et al., 2014) . GANT61-soaked beads were implanted in the right neural fold region. DMSO-soaked beads were grafted as a control in sibling embryos at the same position. In order to inhibit the translation of the gli2 mRNA, a morpholino antisense oligonucleotide (gli2MO) was designed and synthesized including the initiation start site (from +1 to +24 bp) with the sequence shown in Supplementary Table 1 (Gene Tools, LLC). Doses of 5-27 ng/E were microinjected with a lineage tracer into one blastomere in 8-or 16-cell stage embryos. A control antisense morpholino oligonucleotide (CoMO) composed of a random sequence was injected as a control. For the knock-down of gli3, ihh, eg5 and ednra mRNAs, specific morpholino oligonucleotides were used (See Supplementary Table 1 ). The gli2 ORF from pCS2 + 6MT_gli2 was used as a template for DNA constructs and in vitro mRNA synthesis. In order to test the efficacy of gli2MO in vivo, a pCS2 + gli2GFP fusion was generated by high-fidelity PCR using pCS2 + MT_gli2 as the template with the primers shown in Supplementary Table 2 . A fragment containing the N-region of Gli2 encoding 277 amino acid residues of Gli2 was cloned into the pTOPO-TA vector (giving rise to pTOPO-gli2), amplified and then subcloned directionally into BamHI and NcoI sites in pCS2 + eGFP vector to produce the gli2GFP construct. In vitro transcribed mRNA (2.6 ng/E) of this construct was coinjected with different amounts of gli2MO and the GFP fluorescence was observed under a Leica fluorescence stereomicroscope. For the rescue of morpholino knock-down experiments, a DNA construct was prepared by changing specifically the codon sequence targeted by the gli2MO antisense oligonucleotide. Special caution was taken to mutate the DNA sequence without changing the wild type gli2 amino acid sequence. This construct, made by high fidelity PCR and named pCS2 + MT-CRgli2 (CR, Codon Replacement), introduced 6 silent mutations in the nucleotide sequence recognized by the morpholino.
In order to test the different functional variables of Gli2, we generated an activator and a repressor Gli2 construct, gli2act (pCS2 + MT-Gli2act) and gli2rep (pCS2 + MT-Gli2rep), respectively. The activator construct lacks the N-terminal repressor region of Gli2 and the repressor plasmid lacks the C-terminal activator domain of this protein.
These constructs were generated with the primers indicated in Supplementary Table 1 , using pCS2 + MT_gli2 as the template.
The construct gli2PSM (pCS2 + MT-gli2PSM-6xHIS) was generated by site directed mutagenesis and encoded a myc tag in the N-terminal region and a 6xHIS tag in the C-terminal region. Additionally, it has the six PKA-phosphorylatables serine residues mutated into non-phosphorylatable alanines. In order to specifically direct the overexpression of gli2 functional variables to the NCC, the α3000 snail2 promoter (Vallin et al., 2001) was fused upstream to the full length gli2 sequence. The α3000gli2 (Alpha-3000-gli2) DNA construct was prepared from BamHI/NotI digested pTOPO-Gli2 and ligated into SB*XlpSlα3000-GFP plasmid. The α3000gli2 plasmid was purified and 200-400 pg/embryo were microinjected into one blastomere of 8-to 16-cell embryos. Fluorescence was observed since stage 13. Similarly, the constructs α3000-CRgli2 (Alpha-3000-gli2), α3000-gli2act (Alpha-3000-gli2act) and α3000-CRgli2PSM (Alpha-3000-CRgli2PSM) were prepared using the primers described in Supplementary Table 2 . All constructs prepared in this work were sequenced on both strands by automated DNA sequencing and are shown in Supplementary Fig. 1 . Their NCBI accession numbers are indicated in Supplementary Table 5 .
In situ hybridization, immunohistochemistry and caspase activity measurement
The ISH protocol was performed as previously described . Phenotypes obtained by ISH were double-blind counted by two lab members. The NC gene expression areas of treated and injected sides of at least 5 embryos for each treatment or condition were measured and quantified using the ImageJ software (NIH, USA) in 3-5 photographs per embryo. The expression of a gene marker was considered increased or decreased when compared to the control side showed a difference of at least 25% in the average values of gene expression between control and treated sides.
Antisense probes containing Digoxigenin-11-UTP or Fluorescein-12-UTP were prepared from the clones indicated in Supplementary  Table 3 . Apoptosis in NC was detected by Caspase 3/7 activity using the Apo-ONE homogeneous assay (Promega, Madison, WI) according to the manufacturer's instructions as described previously. In detail, NC explants were dissected from midneurula stage embryos. The explants were then resuspended in 50 μl of NAM 3/8 and 50 μl of the Apo-One Caspase 3/7 reagent. After mixing by pipetting to homogenize the tissue, the samples were incubated 40 min at room temperature and the fluorescence was measured as arbitrary fluorescence units in a Perkin-Elmer LS55 fluorescence spectrometer (excitation wavelength 499 nm, emission wavelength 521 nm). The Caspase 3/7 activity was expressed as the ratio to the uninjected embryo (Caspase Arbitrary Unit = 1). (Fernandez et al., 2014) . IHC for Ptch1 and phosphohistone was performed as described previously (Vega-Lopez et al., 2015) . The anti-Ptch1 antibody used was obtained from the Developmental Studies Hybridoma Bank (DSHB, USA, clone Apa1) while the rabbit Polyclonal anti-phosphohistone-3 antibody was obtained from Upstate Biotechnology, Lake Placid, NY). Student's t-test was used to analyze the differences between each of the groups for Caspase 3/7 activity with respect to the corresponding control group. ANOVA analysis (InfoStat 2011, Di Rienzo et al., 2011) was used to determine statistical differences (P ≤ 0.05) between Caspase 3/7 activity and the control group.
Tukey's test was also used (α ≤ 0.05). All experiments were repeated twice.
Cartilage staining, RNA isolation from embryos and RT-qPCR analysis, Western blot and luciferase assay
Cartilage staining was performed as previously described (Vega-Lopez et al., 2015) . For the RT-qPCR study of gli2 function, total RNA was isolated from NC explants using the Trizol LS Reagent (Invitrogen) after microsurgery. After DNaseI treatment, reverse transcription was performed starting from 2 μg of total RNA using the M-MLV Reverse Transcriptase (Promega) and Oligo (dT) primers. Real-time PCR was done on 1 μl of dilutional series of cDNA starting from a dilution of factor 5 using Mezcla Real (Biodynamics). PCR amplification was monitored with a CFX96 Real-Time System (Bio-Rad). After one incubation step at 95°C for 7 min, the thermal cycling protocol was as follows: 95°C for 10 s, 60°C for 15 s and 72°C for 15 s during 40 cycles. The primers designed for this study are shown in Supplementary  Table 4 . Target genes were analyzed using standard curves to determine relative levels of gene expression, and individual cDNA samples were normalized according to the levels of gapdh. For each primer set, the efficiency of the PCR reaction was measured in duplicate on serial dilutions (factor 5) of the cDNA sample. Real-time PCR efficiencies (E) for each reaction were calculated from the slope of the standard curve using the BioRad CFX manager V3 software, with 100% efficiency as an indicator of a robust assay. Statistics were generated using Excel and P values determined using paired, 2-tailed Student's t-Test. Error bars represent average ± s.d. All results reported here are averages of two independent reverse transcription reactions, which have been each tested with two qPCR reactions. For quantification, data were analyzed by the 2-DDCT method (Livak and Schmittgen, 2001) , by normalizing to the housekeeping gene gapdh (glyceraldehyde-3-phosphate dehydrogenase) and to the uninjected NC. Finally, qPCR results were represented showing each gene expression level in treated explants normalized to the level of expression of wildtype uninjected NC explants.
For the control of the efficiency of the gli2MO Western blots were performed as described (Bonano et al., 2008; Fernandez et al., 2014) . Protein extracts were obtained from 10 gli2MO-and pCS2 + gli2GFPinjected embryos at stage 15 for each experimental group and processed for Western blot assay using anti-GFP, 1:1000 (Invitrogen) and antialpha-tubulin 1:1500 (DSHB, 12G10 clone). The alpha-tubulin antibody was used as a loading control. After electrophoresis and electrotransference, nitrocellulose membranes were incubated with primary antibodies overnight at 4°C followed by 2 h incubation with the secondary antibody. The secondary antibodies were peroxidase-conjugated (cat. # AM-P1, Endocrinology Lab, Universidad Nacional del Litoral, Argentina) and alkaline phosphatase (AP)-conjugated (cat. # A0162, Sigma Aldrich) 1:750. The substrates for colorimetric detection were BCIP (cat #94550364, Roche, USA) and NBT (cat. # 94550571, Roche, USA) as AP substrates. For chemiluminescent detection the reagent Biolumina was used (Kalium Tech, Buenos Aires, Agentina). Labeling detection and documentation was performed using a C-Digit scanner (LI-COR Biosciences).
For the luciferase assay, stage 3 embryos were injected with the reporter plasmid 8xGBS-LucII-pCS2+ (a kind gift from Stephan Teglund) (300 pg/E) and the control reporter plasmid pGL4.74-TK-hRluc (200 pg/E). Along with the reporter constructs, mRNAs and MOs were also injected to analyze the transcriptional mechanism involving Gli2. At stages 15-16, 60 NC explants were extracted and homogenized with Passive Lysis Buffer (Promega). Then luciferase activity was measured by a commercial kit (Dual-Luciferase Reporter Assay System, Promega, WI, USA) using the Synergy HTX microplate reader (Biotek, Winooski, VT, USA). Results are representative of two independent experiments.
